Journal Club
December 2017: EARNEST trial looks at long-term efficacy of second-line ART regimens
Article and Study Summary Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Published in: Lancet...
October/November 2017: HPTN 067/ADAPT-Cape Town results on daily versus non-daily PrEP regimens
Article and Study Summary Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial Published in: Lancet HIV. 2017 Oct 3. DOI: http://dx.doi.org/10.1016/S2352-3018(17)30156-X Authors: Bekker...
September 2017: Same-Day ART Initiation in Haiti
Article and Study Summary Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial. Published in: PLoS Med 14(7): e1002357. https://doi.org/10.1371/journal.pmed.1002357 Authors:...